Skip to main content
Top
Published in: Digestive Diseases and Sciences 7/2008

01-07-2008 | Letter to the Editor

Interleukin-10 (-819 C/T) and TNF-A (-308 G/A) as Risk Factors for H. pylori-Associated Gastric MALT-Lymphoma

Authors: Stephan Hellmig, Tobias Bartscht, Wolfgang Fischbach, Ulrich Robert Fölsch, Stefan Schreiber

Published in: Digestive Diseases and Sciences | Issue 7/2008

Login to get access

Excerpt

With great interest we read the article by Achyut et al. about the influence of genetic variants in the promoter region of the Interleukin-10 (IL-10) and tumor necrosis factor alpha (TNF-A) gene on gastritis and lymphoid follicle development in patients with H. pylori infection [1]. The authors genotyped 130 patients with non-ulcer dyspepsia (NUD) and 200 healthy age-matched controls for IL-10 (-819) and TNF-A (-308). They found that carriers of the TNF-A (-308) A allele had a more than twofold increased risk of lymphoid follicle formation. It is generally accepted that the presence of lymphoid follicles and mucosa associated lymphatic tissue (MALT) is solely a sequelae of H. pylori infection [2,3]. Pro-inflammatory genetic polymorphisms may influence the histological degree of mucosal inflammation [4] which may vary according to the localization of the biopsy. To identify a robust association of germline polymorphisms with the outcome of H. pylori infection, unambiguous phenotypes such as ulcer disease, gastric carcinoma, or primary gastric B-cell lymphoma are needed. …
Literature
1.
go back to reference Achyut BR, Tripathi P, Ghoshal UC, Moorchung N, Mittal B (2007) Interleukin-10 (-819 c/t) and tumor necrosis factor-alpha (-308 g/a) gene variants influence gastritis and lymphoid follicle development. Dig Dis Sci Achyut BR, Tripathi P, Ghoshal UC, Moorchung N, Mittal B (2007) Interleukin-10 (-819 c/t) and tumor necrosis factor-alpha (-308 g/a) gene variants influence gastritis and lymphoid follicle development. Dig Dis Sci
2.
go back to reference Genta RM, Hamner HW (1994) The significance of lymphoid follicles in the interpretation of gastric biopsy specimens. Arch Pathol Lab Med 118:740–743PubMed Genta RM, Hamner HW (1994) The significance of lymphoid follicles in the interpretation of gastric biopsy specimens. Arch Pathol Lab Med 118:740–743PubMed
3.
go back to reference Stolte M, Eidt S (1989) Lymphoid follicles in antral mucosa: Immune response to campylobacter pylori? J Clin Pathol 42:1269–1271PubMedCrossRef Stolte M, Eidt S (1989) Lymphoid follicles in antral mucosa: Immune response to campylobacter pylori? J Clin Pathol 42:1269–1271PubMedCrossRef
4.
go back to reference Rad R, Dossumbekova A, Neu B, Lang R, Bauer S, Saur D, Gerhard M, Prinz C (2004) Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 53:1082–1089PubMedCrossRef Rad R, Dossumbekova A, Neu B, Lang R, Bauer S, Saur D, Gerhard M, Prinz C (2004) Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 53:1082–1089PubMedCrossRef
5.
go back to reference Hellmig S, Fischbach W, Goebeler-Kolve ME, Folsch UR, Hampe J, Schreiber S (2005) A functional promotor polymorphism of tnf-alpha is associated with primary gastric b-cell lymphoma. Am J Gastroenterol 100:2644–2649PubMedCrossRef Hellmig S, Fischbach W, Goebeler-Kolve ME, Folsch UR, Hampe J, Schreiber S (2005) A functional promotor polymorphism of tnf-alpha is associated with primary gastric b-cell lymphoma. Am J Gastroenterol 100:2644–2649PubMedCrossRef
6.
go back to reference Fischbach W, Dragosics B, Kolve-Goebeler ME, Ohmann C, Greiner A, Yang Q, Bohm S, Verreet P, Horstmann O, Busch M, Duhmke E, Muller-Hermelink HK, Wilms K, Allinger S, Bauer P, Bauer S, Bender A, Brandstatter G, Chott A, Dittrich C, Erhart K, Eysselt D, Ellersdorfer H, Ferlitsch A, Fridrik MA, Gartner A, Hausmaninger M, Hinterberger W, Hugel K, Ilsinger P, Jonaus K, Judmaier G, Karner J, Kerstan E, Knoflach P, Lenz K, Kandutsch A, Lobmeyer M, Michlmeier H, Mach H, Marosi C, Ohlinger W, Oprean H, Pointer H, Pont J, Salabon H, Samec HJ, Ulsperger A, Wimmer A, Wewalka F (2000) Primary gastric b-cell lymphoma: Results of a prospective multicenter study. The german-austrian gastrointestinal lymphoma study group. Gastroenterology 119:1191–1202PubMedCrossRef Fischbach W, Dragosics B, Kolve-Goebeler ME, Ohmann C, Greiner A, Yang Q, Bohm S, Verreet P, Horstmann O, Busch M, Duhmke E, Muller-Hermelink HK, Wilms K, Allinger S, Bauer P, Bauer S, Bender A, Brandstatter G, Chott A, Dittrich C, Erhart K, Eysselt D, Ellersdorfer H, Ferlitsch A, Fridrik MA, Gartner A, Hausmaninger M, Hinterberger W, Hugel K, Ilsinger P, Jonaus K, Judmaier G, Karner J, Kerstan E, Knoflach P, Lenz K, Kandutsch A, Lobmeyer M, Michlmeier H, Mach H, Marosi C, Ohlinger W, Oprean H, Pointer H, Pont J, Salabon H, Samec HJ, Ulsperger A, Wimmer A, Wewalka F (2000) Primary gastric b-cell lymphoma: Results of a prospective multicenter study. The german-austrian gastrointestinal lymphoma study group. Gastroenterology 119:1191–1202PubMedCrossRef
7.
go back to reference Hellmig S, Hampe J, Folsch UR, Schreiber S (2005) Role of il-10 promoter haplotypes in helicobacter pylori associated gastric inflammation. Gut 54:888PubMedCrossRef Hellmig S, Hampe J, Folsch UR, Schreiber S (2005) Role of il-10 promoter haplotypes in helicobacter pylori associated gastric inflammation. Gut 54:888PubMedCrossRef
Metadata
Title
Interleukin-10 (-819 C/T) and TNF-A (-308 G/A) as Risk Factors for H. pylori-Associated Gastric MALT-Lymphoma
Authors
Stephan Hellmig
Tobias Bartscht
Wolfgang Fischbach
Ulrich Robert Fölsch
Stefan Schreiber
Publication date
01-07-2008
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 7/2008
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-008-0231-0

Other articles of this Issue 7/2008

Digestive Diseases and Sciences 7/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.